These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30424975)

  • 1. Sentinel node biopsy for melanoma: New Zealand indication guidelines in practice
    Brian T; McEwan W; Jameson MB
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):137-171. PubMed ID: 30424975
    [No Abstract]   [Full Text] [Related]  

  • 2. Option grids in melanoma: An underused tool.
    Ward J; Butt U; Powell B
    J Plast Reconstr Aesthet Surg; 2018 May; 71(5):763-764. PubMed ID: 29233506
    [No Abstract]   [Full Text] [Related]  

  • 3. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
    Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
    Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
    Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
    Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
    El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ
    Ann Surg Oncol; 2019 May; 26(5):1494-1502. PubMed ID: 30719636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands.
    Verstijnen J; Damude S; Hoekstra HJ; Kruijff S; Ten Tije AJ; Louwman WJ; Bastiaannet E; Stuiver MM
    Surg Oncol; 2017 Dec; 26(4):431-437. PubMed ID: 29113662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sentinel lymph node biopsy].
    Hauschild A
    Hautarzt; 2005 Sep; 56(9):888-9. PubMed ID: 16345140
    [No Abstract]   [Full Text] [Related]  

  • 8. Choosing to biopsy or refer suspicious melanocytic lesions in general practice.
    Robison S; Kljakovic M; Barry P
    BMC Fam Pract; 2012 Aug; 13():78. PubMed ID: 22873705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National practice patterns of sentinel lymph node dissection for breast carcinoma.
    Lucci A; Kelemen PR; Miller C; Chardkoff L; Wilson L
    J Am Coll Surg; 2001 Apr; 192(4):453-8. PubMed ID: 11294401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in melanoma.
    Uren RF
    J Nucl Med; 2006 Feb; 47(2):191-5. PubMed ID: 16455622
    [No Abstract]   [Full Text] [Related]  

  • 12. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice patterns in sentinel lymph node biopsy.
    Bold RJ; Fahy BN
    J Am Coll Surg; 2001 Oct; 193(4):466-7. PubMed ID: 11584980
    [No Abstract]   [Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in melanoma: Facts and controversies.
    Baldwin BT; Cherpelis BS; Sondak V; Fenske NA
    Clin Dermatol; 2010; 28(3):319-23. PubMed ID: 20541686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sentinel node biopsy. What are the facts?].
    Möhrle M; Breuninger H
    Hautarzt; 2005 May; 56(5):441-7. PubMed ID: 15887051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
    Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
    J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference?
    Rivard J; Kostaras X; Shea-Budgell M; Chin-Lenn L; Quan ML; McKinnon JG
    J Surg Oncol; 2015 Aug; 112(2):173-8. PubMed ID: 26445222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy and the U.K. guidelines for cutaneous melanoma.
    Phillips WG
    Br J Dermatol; 2002 Oct; 147(4):834. PubMed ID: 12366455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of sentinel node biopsy considering melanoma management as an example].
    Loquai C; Riemann H; Grabbe S
    Urologe A; 2005 Jun; 44(6):625-9. PubMed ID: 15891866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel-lymph-node biopsy for cutaneous melanoma.
    Gershenwald JE; Ross MI
    N Engl J Med; 2011 May; 364(18):1738-45. PubMed ID: 21542744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.